Fondazione IRCCS Istituto Nazionale dei Tumori (INT)

Published on 06-Sep-2012

"By providing our physicians with vital input on what worked best for patients with similar clinical characteristics, we can help improve treatment effectiveness and the final patient outcome." - Dr. Marco A. Pierotti

Customer:
Fondazione IRCCS Istituto Nazionale dei Tumori (INT)

Industry:
Healthcare

Deployment country:
Italy

Solution:
BA - Business Analytics, BA - Business Intelligence, Big Data & Analytics, Big Data & Analytics: Operations/Fraud/Threats, Industry Framework , Smarter Planet

Smarter Planet:
Smarter Cities, Smarter Healthcare

Overview

Fondazione IRCCS Istituto Nazionale dei Tumori (INT) was founded in 1925 in Milan, and is recognized as a scientific research and treatment institution in the field of pre-clinical and clinical oncology.

Business need:
INT, a leading Italian cancer treatment and research center, wanted to improve patient care by tailoring treatment approaches to specific individuals. The institute needed the ability to analyze past treatments and cases, and combine that information with the patient’s personal statistics and disease profile, to create a fact-based treatment plan for each patient. In addition, being able to analyze overall outcome data would help the institute provide more cost-effective, efficient care for its patients.

Solution:
Personalized medicine is being implemented at INT, where an in-depth analysis of a patient’s disease profile, combined with analysis of past cases, enables doctors to provide an optimal treatment plan for each patient. The solution proactively shows the physician statistics on similar clinical cases, possible alternative treatments and predicted outcomes for each. One insight showed that physicians tend to give more aggressive medical therapy to women who are sick as opposed to men with the same problem. Knowing this, physicians can ensure that patients receive only the procedures they need.

Benefits:
Avoids unnecessary treatment (estimated to be up to 60 percent of all treatment) and delays in treatment delivery Creates tailored and personalized treatments, increasing the chances of successful outcomes Improves hospital performance, both clinical and operational, by providing a “big picture” view of treatment delivery, helping streamline processes and lower costs

Case Study

Fondazione IRCCS Istituto Nazionale dei Tumori (INT) was founded in 1925 in Milan, and is recognized as a scientific research and treatment institution in the field of pre-clinical and clinical oncology.

The Opportunity
INT, a leading Italian cancer treatment and research center, wanted
to improve patient care by tailoring treatment approaches to specific individuals. The institute needed the ability to analyze past treatments and cases, and combine that information with the patient’s personal statistics and disease profile, to create a fact-based treatment plan for each patient. In addition, being able to analyze overall outcome data would help the institute provide more cost-effective, efficient care for its patients.

What Makes It Smarter
True evidence-based, personalized medicine is being implemented at INT, where an in-depth analysis of a patient’s personal makeup and disease profile, combined with insight gained from the analysis of past cases and clinical guidelines, enables doctors to provide an optimal treatment plan for each patient. The solution proactively shows the physician statistics on similar clinical cases, possible alternative treatments and predicted outcomes for each, allowing the doctor to make a truly informed decision. One insight from the solution showed that, statistically, physicians tend to give more aggressive medical therapy to women who are sick as opposed to men with the same problem. Knowing this, physicians can guard against such overtreatment, ensuring that patients receive only the medicine and procedures they need.

Real Business Results
· Avoids unnecessary treatment (estimated to be up to 60 percent of all treatment) and delays in treatment delivery
· Creates tailored and personalized treatments, increasing the chances of successful outcomes
· Improves hospital performance, both clinical and operational, by providing a “big picture” view of treatment delivery, helping streamline processes and lower costs

Products and services used

IBM products and services that were used in this case study.

Software:
SPSS Advanced Statistics, IBM ILOG Rules for C++, Cognos Business Intelligence, WebSphere Application Server, DB2 Enterprise Server Edition, JRules

Legal Information

© Copyright IBM Corporation 2012 IBM Corporation Software Group Route 100 Somers, NY 10589 Produced in the United States August 2012 IBM, the IBM logo, ibm.com, Cognos, DB2, Global Business Services, ILOG, SPSS and WebSphere are trademarks of International Business Machines Corp., registered in many jurisdictions worldwide. Other product and service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.shtml This document is current as of the initial date of publication and may be changed by IBM at any time. Not all offerings are available in every country in which IBM operates. The performance data and client examples cited are presented for illustrative purposes only. Actual performance results may vary depending on specific configurations and operating conditions. THE INFORMATION IN THIS DOCUMENT IS PROVIDED “AS IS” WITHOUT ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTY OR CONDITION OF NON-INFRINGEMENT. IBM products are warranted according to the terms and conditions of the agreements under which they are provided.